ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway

Zou, Chen; Wu, Siyuan; Wei, Haigang; Luo, Hailing; Tang, Zhe; Li, Xia; Lv, Xiaozhi*; Ai, Yilong*佛山科学技术学院; 南方医科大学
Journal of Immunology Research2021-7-27DOI: 10.1155/2021/1830790
5被引6阅读
引用收藏
分享

摘要

LINC01355 has been demonstrated to be dysregulated in several cancers. However, the exact molecular function of LINC01355 in the pathogenesis of OSCC remains unstudied. Here, we reported the effect of LINC01355 in OSCC and investigated the mechanisms. Firstly, we found that the results indicated LINC01355 was increased in OSCC cells. Knockdown of LINC01355 repressed OSCC cell proliferation, migration, and invasion. Recently, immunotherapy is a significant method for the treatment of cancers, in which CD8+ T cells exhibit a significant role. The influence of LINC01355 on the antitumor activity of CD8+ T cells was also focused in this study. As shown, the silence of LINC01355 could repress OSCC tumor growth via inducing CD8+ T cell immune responses. In addition, we found that downregulation of LINC01355 significantly restrained CD8+ T cell apoptosis, induced CD8+ T cell percentage, and enhanced the cytolysis activity when cocultured with OSCC cells. It has been reported that the Notch pathway represses CD8+ T cell activity in cancer patients. In our present study, we displayed that lack of LINC01355 suppressed OSCC malignant behaviors and enhanced the antitumor activity of CD8+ T cells via inactivating Notch signaling. We showed that decreased LINC01355 significantly restrained the Notch signal via a decrease of Notch-1, JAG-1, and HES-1. Repression of Notch1 reversed the effect of LINC01355 in OSCC cells. In conclusion, it was implied that LINC01355 might induce the development of OSCC via modulating the Notch signal pathway, which could provide a candidate therapeutic target for OSCC.

学科与关键词

关键词
LONG NONCODING RNACANCERPROGRESSIONPROMOTESROLES
相关
加载中…
  • LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect malignant development of oral squamous cell carcinoma
    Dong, Chen; Zhao, Yanmei; Yang, Song; Jiao, Xiaohui*Journal of Oral Pathology and Medicine, 2023, 52(6): 493-503.被引 2
  • LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway
    Jia, Bo; Dao, Junfeng; Han, Jiusong; Huang, Zhijie; Sun, Xiang; Zheng, Xianghuai; Xiang, Shijian; Zhou, Huixi*; Liu, Shuguang*Cancer Cell International, 2021, 21(1): 147.被引 21
  • Repression of CRNDE enhances the anti-tumour activity of CD8+T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3
    Ai, Yilong; Wu, Siyuan; Gao, Hai; Wei, Haigang; Tang, Zhe; Li, Xia*; Zou, Chen*Journal of Cellular and Molecular Medicine, 2021, 25(23): 10857-10868.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2021-07-27
卷期
第 2021 卷
页码
1830790
DOI
10.1155/2021/1830790
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zou, Chen (第一作者)

    foshan univ

  • W

    Wu, Siyuan

    foshan univ

查看全部 8 位作者收起作者
  • W

    Wei, Haigang

    foshan univ

  • L

    Luo, Hailing

    foshan univ

  • T

    Tang, Zhe

    foshan univ

  • L

    Li, Xia

    foshan univ

  • L

    Lv, Xiaozhi (通讯)

    southern med univ

  • A

    Ai, Yilong (通讯)

    foshan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417